Antibiotics and renal branching morphogenesis: Comparison of toxicities

Pediatric Research

Volumn 76, Issue 6, 2014, Pages 508-514

  Bueters, Ruud R G ^a   Kusters, Lisanne J A ^a   Klaasen, Annelies ^a   Van Den Heuvel, Lambertus P ^a   Schreuder, Michiel F ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 9; CEFTAZIDIME; FIBROBLAST GROWTH FACTOR 8; GENTAMICIN; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; MEROPENEM; MESSENGER RNA; OSTEOGENIC PROTEIN 1; TRANSCRIPTION FACTOR SOX9; WT1 PROTEIN; ANTIINFECTIVE AGENT; FGF8 PROTEIN, MOUSE; GDNF PROTEIN, MOUSE; THIENAMYCIN DERIVATIVE;

ANIMAL TISSUE; ANTIBIOTIC THERAPY; APOPTOSIS; ARTICLE; BRANCHING MORPHOGENESIS; COMPARATIVE STUDY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DOWN REGULATION; DRUG RESPONSE; FEMALE; GENE EXPRESSION; KIDNEY DEVELOPMENT; KIDNEY SIZE; MOUSE; NONHUMAN; ORGAN CULTURE; URETER; ANIMAL; DOSE RESPONSE; DRUG EFFECTS; EMBRYOLOGY; GENE EXPRESSION REGULATION; GENETICS; GESTATIONAL AGE; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; MORPHOGENESIS; NEPHRON; TISSUE CULTURE TECHNIQUE;

ANIMALS; ANTI-BACTERIAL AGENTS; CEFTAZIDIME; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLAST GROWTH FACTOR 8; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENTAMICINS; GESTATIONAL AGE; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; MICE, INBRED ICR; MORPHOGENESIS; NEPHRONS; THIENAMYCINS; TISSUE CULTURE TECHNIQUES; URETER;

EID: 84910604977     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2014.127     Document Type: Article

References (33)

1. Schreuder M, Delemarre-van de Waal H, van Wijk A. Consequences of intrauterine growth restriction for the kidney. Kidney Blood Press Res 2006;29:108-25.
2. The Netherlands Perinatal Registry. Registry Perinatal care in the Netherlands 2005. Utrecht, the Netherlands: The Netherlands Perinatal Registry, 2008.
3. Gilbert T, Lelievre-Pegorier M, Malienou R, Meulemans A, Merlet-Benichou C. Effects of prenatal and postnatal exposure to gentamicin on renal differentiation in the rat. Toxicology 1987;43:301-13.
4. Gilbert T, Lelievre-Pegorier M, Merlet-Benichou C. Long-term effects of mild oligonephronia induced in utero by gentamicin in the rat. Pediatr Res 1991;30:450-6.
5. Gilbert T, Nabarra B, Merlet-Benichou C. Light- and electron-microscopic analysis of the kidney in newborn rats exposed to gentamicin in utero. Am J Pathol 1988;130:33-43.
6. Schwedler SB, Gilbert T, Moreau E, Striker LJ, Merlet-Benichou C, Striker GE. Nephrotoxin exposure in utero reduces glomerular number in sclerosis-prone but not sclerosis-resistant mice. Kidney Int 1999;56:1683-90.
7. Gilbert T, Cibert C, Moreau E, Geraud G, Merlet-Benichou C. Early defect in branching morphogenesis of the ureteric bud in induced nephron deficit. Kidney Int 1996;50:783-95.
8. Tune BM. Nephrotoxicity of beta-lactam antibiotics: mechanisms and strategies for prevention. Pediatr Nephrol 1997;11:768-72.
9. Topham JC, Murgatroyd LB, Jones DV, Goonetilleke UR, Wright J. Safety evaluation of meropenem in animals: studies on the kidney. J Antimicrob Chemother 1989;24:Suppl A:287-306.
10. Bax RP, Bastain W, Featherstone A, Wilkinson DM, Hutchison M, Haworth SJ. The pharmacokinetics of meropenem in volunteers. J Antimicrob Chemother 1989;24:Suppl A:311-20.
11. Norrby SR, Newell PA, Faulkner KL, Lesky W. Safety profile of meropenem: international clinical experience based on the first 3125 patients treated with meropenem. J Antimicrob Chemother 1995;36:Suppl A:207-23.
12. Chan SK, Riley PR, Price KL, et al. Corticosteroid-induced kidney dysmorphogenesis is associated with deregulated expression of known cystogenic molecules, as well as Indian hedgehog. Am J Physiol Renal Physiol 2010;298:F346-56.
13. Sebinger DD, Unbekandt M, Ganeva VV, Ofenbauer A, Werner C, Davies JA. A novel, low-volume method for organ culture of embryonic kidneys that allows development of cortico-medullary anatomical organization. PLoS ONE 2010;5:e10550.
14. Costantini F. GDNF/Ret signaling and renal branching morphogenesis: From mesenchymal signals to epithelial cell behaviors. Organogenesis 2010;6:252-62.
15. Rosines E, Johkura K, Zhang X, et al. Constructing kidney-like tissues from cells based on programs for organ development: toward a method of in vitro tissue engineering of the kidney. Tissue Eng Part A 2010;16:2441-55.
16. Srinivas S, Goldberg MR, Watanabe T, DAgati V, al-Awqati Q, Costantini F. Expression of green fluorescent protein in the ureteric bud of transgenic mice: a new tool for the analysis of ureteric bud morphogenesis. Dev Genet 1999;24:241-51.
17. Kent AL, Douglas-Denton R, Shadbolt B, et al. Indomethacin, ibuprofen and gentamicin administered during late stages of glomerulogenesis do not reduce glomerular number at 14 days of age in the neonatal rat. Pediatr Nephrol 2009;24:1143-9.
18. Lelievre-Pegorier M, Gilbert T, Sakly R, Meulemans A, Merlet-Benichou C. Effect of fetal exposure to gentamicin on kidneys of young guinea pigs. Antimicrob Agents Chemother 1987;31:88-92.
19. Richardson L, Venkataraman S, Stevenson P, et al. EMAGE mouse embryo spatial gene expression database: 2010 update. Nucleic Acids Res 2010;38(Database issue):D703-9.
20. Ortiz LA, Quan A, Weinberg A, Baum M. Effect of prenatal dexamethasone on rat renal development. Kidney Int 2001;59:1663-9.
21. Perantoni AO, Timofeeva O, Naillat F, et al. Inactivation of FGF8 in early mesoderm reveals an essential role in kidney development. Development 2005;132:3859-71.
22. Grieshammer U, Cebrin C, Ilagan R, Meyers E, Herzlinger D, Martin GR. FGF8 is required for cell survival at distinct stages of nephrogenesis and for regulation of gene expression in nascent nephrons. Development 2005;132:3847-57.
23. Dudley AT, Godin RE, Robertson EJ. Interaction between FGF and BMP signaling pathways regulates development of metanephric mesenchyme. Genes Dev 1999;13:1601-13.
24. Araki T, Hayashi M, Nakanishi K, Morishima N, Saruta T. Caspase-9 takes part in programmed cell death in developing mouse kidney. Nephron Exp Nephrol 2003;93:e117-24.
25. Nathanson S, Moreau E, Merlet-Benichou C, Gilbert T. In utero and in vitro exposure to beta-lactams impair kidney development in the rat. J Am Soc Nephrol 2000;11:874-84.
26. Dutch Health Institute. Meropenem, 2013. (http://www.fk.cvz.nl/ preparaatteksten/m/meropenem.asp.)
27. Lam YW, Duroux MH, Gambertoglio JG, Barriere SL, Guglielmo BJ. Effect of protein binding on serum bactericidal activities of ceftazidime and cefoperazone in healthy volunteers. Antimicrob Agents Chemother 1988;32:298-302.
28. van den Anker JN, Schoemaker RC, Hop WC, et al. Ceftazidime pharmacokinetics in preterm infants: effects of renal function and gestational age. Clin Pharmacol Ther 1995;58:650-9.
29. Craig WA. The pharmacology of meropenem, a new carbapenem antibiotic. Clin Infect Dis 1997;24:Suppl 2:S266-75.
30. Meropenem: pediatric drug information. In: Basow D, ed. UpToDate. Waltham, MA, 2013.
31. Dutch Health Institute. Gentamicin, 2013. (http://www.fk.cvz.nl/ preparaatteksten/g/gentamicine%20(systemisch).asp.)
32. Dutch Health Institute. Ceftazidime, 2013. (http://www.fk.cvz.nl/ preparaatteksten/c/ceftazidim.asp.)
33. Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods 2012;9:671-5.